Euoko Group Inc. (OTCBB: EUOK)Euoko Group Inc. (OTCBB: EUOK) – Wednesday’s shares stayed even at $0.230. The volume was 17,595. Kris Gupta, CFA for Equity Stock Analysis, issued a research report regarding the future potential of Euoko Group. The full report is available at http://www.equitystockanalysis.com. In the report, Kris Gupta writes, �Euoko Group Inc. is engaged in the business of development, marketing and distribution of luxury and mainstream skin treatments. It offers twenty-four luxury skin treatment products categorized into five collections: R-Series for enhancing skin radiance, Y-Series for targeting lines and wrinkles, A-Series for blemish-prone skin, P-Series for diverse environmental protection and W-Series for correcting pigmentation problems.
Euoko Group Inc. owns premium brands that develop, market and distribute scientifically-advanced skin treatments, including the brand, Euoko. Euoko’s current portfolio consists of 24 products spanning five treatment collections that target aging, dull skin tones, skin protection, uneven pigmentation and blemishes. This product line offers comprehensive solutions to such skin concerns as wrinkles, fine lines, under-eye dark circles, dark spots, acne, oxidation, environmental exposure and skin fatigue. Combined with innovative products for basic daily cleansing and facial priming, Euoko offers a complete line of synergistic formulations that target the most demanding luxury consumer. Euoko’s well-appointed, understated primary and secondary packaging communicates innovation, science and modern sophistication, while reflecting the prestige positioning of the portfolio. Euoko sells its product line through premium distribution channels and is represented in more than fifteen countries and territories worldwide. Retail partners of the brand include such premium department stores as Bergdorf Goodman in New York City (USA), Printemps in Paris (France) and La Rinascente in Milan (Italy). Euoko’s products are also sold globally through the company’s internally-operated, multicurrency, multilingual website.
Metro One Development, Inc. (OTCBB: MODI)
Metro One Development, Inc. (OTCBB: MODI) – Wednesday’s shares decreased 9.09% to $0.10. 61,475 was the volume. Metro One Development, a custom builder and property developer in the Greater Toronto Area (’GTA’), Canada, announced April 18th that the Company has introduced ‘One’, their initial residential design. The first of many floor plans being developed, ‘One’ is a 3 bedroom, 4 bathroom, 2500 sq. ft. family home. A copy of the floor plan may be viewed at http://www.metro-one.com/one.html. Metro One CEO Stuart Turk commented, “Metro One is pleased to introduce a residential design we feel will have market appeal. We are actively considering several strong areas in the GTA for this residential project. Our proprietary designs are shaping up as we focus on an affluent audience’s near term desires, as well as what that market will appreciably bear in years to come. We look forward to introducing many new designs over the course of the next few months.”
Metro One Development, Inc., previously On The Go Healthcare, Inc., acquires and renovates, to specification, residential (single dwelling and multi-unit), commercial and industrial properties in the Greater Toronto Area (GTA), Ontario, Canada. Whether it’s an existing property or something developed from ‘the ground up’, a smaller home project or a large fully customized and scalable development, the company fabricates the foundations and architecture to create a personalized design solution, tailored to the client’s demands and space intentions. The company also facilitates, and continually invests in, the best available professional and contractual services in the GTA area, as well as obtains and clears all necessary Municipal Residential, Building, Fire and Occupancy permits.
NextGen Bioscience, Inc. (OTC: NXGB)
NextGen Bioscience, Inc. (OTC: NXGB) – Wednesday’s shares closed down 11.25% to $0.071. 71,350 shares were traded. NextGen Bioscience, announced April 17th that it entered into discussion about collaboration with Oxon Life Science (”Oxon”), from whom it has recently acquired use, commercialisation and ownership rights of a patent application for the treatment of cancer, regarding the development of the latest stem cell technology that NXGB has acquired from Oxon in that transaction. NextGen CEO, Konstantinos Kardiasmenos, stated, “NextGen is excited about the possibility of close collaboration with Oxon. NextGen’s proprietary technology, which we have acquired from Oxon, has the potential to treat breast cancer by more precisely targeting the cancer cells.”
NextGen Bioscience, Inc. is a drug development biotechnology company focused on the identification, evaluation and acquisition of drug candidates for treatment and prevention of oncological and infectious diseases in human beings. All product candidates target indications with significant unmet need and substantial market potential. Subsequent value-addition at low cost brings benefits to both patients and stakeholders. These programs will then be transferred to larger organizations, either other biotech companies and/or Big Pharma, who have the infrastructure to bring the products to market.
China Voice Holding Corp. (OTC: CHVC)
China Voice Holding Corp. (OTC: CHVC) – Wednesday’s shares stayed even at $0.56. The volume was 380,247. China Voice Holding Corporation, announced April 15th that it hired James Rapant as Vice President of Business Development for its wholly owned U.S. subsidiary, CVC International, Inc. (CVC). Mr. Rapant will focus on maximizing the profitability of the Company�s new Prepaid Calling Card products and broadening the base of Suppliers for its wholesale termination business. CHVC�s President and CEO Bill Burbank said, �James brings over 16 years of Sales and Business Development experience to the Company. He has vast experience in working with Telecom Carriers and the platforms utilized to support Wholesale Origination and Termination, and Calling Card products. With the Company�s newly expanded network infrastructure and growing U.S. revenues in prepaid calling cards and prepaid cellular products, James is a perfect fit. Since last June, CHVC has been acquiring and establishing many U.S. subsidiaries to support growth in the prepaid calling card and wholesale termination business. Now that we have accomplished our goal of building this business to over $70 Million in annualized revenues, it is time to enter the next phase of our Business Plan to focus on substantially increasing operating margins. The objective will be to establish our Calling Card brand that uses our network and to open new direct international routes for our wholesale termination business while increasing margins.�
China Voice Holding Corp. has a portfolio of next-generation communications products and services doing business in the People’s Republic of China and the U.S. Through its subsidiaries, the Company provides Voice over Internet Protocol (”VoIP”) telephone services, office automation, wireless broadband, unified messaging, video conferencing, mobility services and other advanced voice and data services in China, where the Company has obtained full legal status as a licensed telecommunications company. The Chinese telecommunications market is the largest and fastest growing in the world. CHVC’s focus is on providing innovative telecommunication applications and solutions to customers. CHVC plans to grow its customer base in China and other parts of the world through marketing and sales efforts as well as acquiring and merging with synergistic companies.